Press Release: gBETA Medtech Announces Summer 2018 Cohort

gBETA.png

Minneapolis, MN – gBETA Medtech, a program of the nationally ranked accelerator gener8tor, announced the six startups that were selected for its Summer 2018 cohort. gBETA Medtech is funded by Boston Scientific, with additional support from Mayo Clinic, the University of Minnesota, and Medical Alley Association.

gBETA Medtech is a free, seven-week accelerator that works with medical device, healthcare-related software, biotech and diagnostics startups. Each gBETA program is capped at six companies, and requires no fees and takes no equity. Participants receive intensive and individualized coaching and access to physicians, researchers, successful entrepreneurs, angel investors, venture capitalists and industry experts. The program is designed to help startups gain early customer traction on their product or idea, and establish metrics that can make them competitive applicants for full-time, equity-based accelerators or seed investment.

The gBETA Medtech Summer 2018 cohort consists of six startups selected from an international applicant pool. Descriptions for all six companies can be found below.

“As gBETA Medtech builds momentum with this second cohort, we’re encouraged by the increasing diversity of the applicants drawn to Medical Alley,” said Adam Choe, director of gBETA Medtech. “With companies from across the country focused on a wide range of patient needs, we’re confident that this group will maximize the opportunities to engage with mentors, investors and strategic organizations during our seven-week program and will bring the best of Minnesota’s medtech cluster back to their local markets.”

  • InterShunt (St. Louis, Missouri) designs and develops a catheter based minimally-invasive procedure, without an implant, to provide relief for millions suffering from heart failure.
    CEO: Harlee Sorkin | harlee@intershunt.com| www.intershunt.com

  • Lucia Health Guidelines (San Francisco, California) uses artificial intelligence and machine learning to facilitate clinician adherence to American Heart Association guidelines in order to close gaps in care.
    CEO: Mathew Rothway | mathew@luciaguidelines.comwww.luciaguidelines.com

  • Morari Medical (Minneapolis, Minnesota) is restoring confidence in male sexual health by eliminating the embarrassment and frustration of sexual dysfunction.
    CEO: Jeff Bennett | jbennett@morarimedical.comwww.morarimedical.com

  • Noleus Technologies (Houston, Texas) designs and develops a disposable device that mitigates postoperative bowel swelling to accelerate patient recovery after abdominal surgery.          CEO: Swarna Balasubramaniam, MD | swarna@noleustechnologies.com|www.noleustechnologies.com

  • Sunrise Health (Boston, Massachusetts) provides patients with mental health or substance use conditions 24/7 access to anonymous, text-based group support.                                          CEO: Shrenik Jain | shrenik@sunrisehealth.co| www.sunrisehealth.co

  • SuraMedical (Minneapolis, Minnesota) increases the consistency in chronic leg wound treatment by remotely monitoring critical aspects of chronic care.
    CEO: Marja Engel | marja.engels@suramedical.comwww.suramedical.com

    gBETA Medtech is now accepting applications for the Fall 2018 cohort. Applications are open to startups across the globe. Startups interested in applying should contact gBETA Medtech Director Adam Choe (adam@gener8tor.com). For more information on the program and ways to get involved, please visit www.gbetamedtech.com.